Component
Isoproterenol
Experimental species, exposure and limitations are retained on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
Where it participates (unsigned role)
Co-applying 6-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle.
Experimental context and source evidence
- dose
- 6- or 8-gingerol 100 micromolar with isoproterenol concentration-response
- duration
- Acute relaxation assay; exact duration not in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human airway smooth muscle tissue in organ baths
- limitations
- High experimental parent-compound exposure; not clinical inhaler potentiation or a recommended co-treatment.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human airway smooth muscle tissue in organ baths
- plain_language
- Co-applying 6-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle.
- primary_references
- Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins. (2014). https://pubmed.ncbi.nlm.nih.gov/23962082/ DOI: 10.1165/rcmb.2013-0133OC
- route
- Ex vivo tissue bath
- tissue
- Airway smooth muscle
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 184–193
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human airway smooth muscle tissue in organ baths · source_derived_draft · unverified_draft
## gingerols-6-isoproterenol Co-applying 6-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle. Model/species: Human airway smooth muscle tissue in organ baths Tissue: Airway smooth muscle Exposure: 6- or 8-gingerol 100 micromolar with isoproterenol concentration-response Route: Ex vivo tissue bath Duration: Acute relaxation assay; exact duration not in accessed abstract Limits: High experimental parent-compound exposure; not clinical inhaler potentiation or a recommended co-treatment. Primary reference: Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins. (2014). https://pubmed.ncbi.nlm.nih.gov/23962082/ DOI: 10.1165/rcmb.2013-0133OC Access: Primary PubMed abstract.
Complete structured claim and evidenceCo-applying 8-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle.
Experimental context and source evidence
- dose
- 6- or 8-gingerol 100 micromolar with isoproterenol concentration-response
- duration
- Acute relaxation assay; exact duration not in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human airway smooth muscle tissue in organ baths
- limitations
- High experimental parent-compound exposure; not clinical inhaler potentiation or a recommended co-treatment.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human airway smooth muscle tissue in organ baths
- plain_language
- Co-applying 8-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle.
- primary_references
- Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins. (2014). https://pubmed.ncbi.nlm.nih.gov/23962082/ DOI: 10.1165/rcmb.2013-0133OC
- route
- Ex vivo tissue bath
- tissue
- Airway smooth muscle
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 206–215
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human airway smooth muscle tissue in organ baths · source_derived_draft · unverified_draft
## gingerols-8-isoproterenol Co-applying 8-gingerol enhanced isoproterenol-induced relaxation of isolated human airway smooth muscle. Model/species: Human airway smooth muscle tissue in organ baths Tissue: Airway smooth muscle Exposure: 6- or 8-gingerol 100 micromolar with isoproterenol concentration-response Route: Ex vivo tissue bath Duration: Acute relaxation assay; exact duration not in accessed abstract Limits: High experimental parent-compound exposure; not clinical inhaler potentiation or a recommended co-treatment. Primary reference: Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins. (2014). https://pubmed.ncbi.nlm.nih.gov/23962082/ DOI: 10.1165/rcmb.2013-0133OC Access: Primary PubMed abstract.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.